Aurobindo Pharma Limited (AUROPHARMA.BO)

INR 1264.95

(1.37%)

Market Cap (In INR)

734.68 Billion

Revenue (In INR)

287.04 Billion

Net Income (In INR)

31.72 Billion

Avg. Volume

44.11 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
959.05-1592.55
PE
-
EPS
-
Beta Value
0.593
ISIN
INE406A01037
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D.
Employee Count
-
Website
https://www.aurobindo.com
Ipo Date
2000-01-03
Details
Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.